Dr Mehra discussed HPV-positive oropharyngeal cancer, focusing on balancing high cure rates while minimizing toxicity through careful patient selection.
Ranee Mehra, MD
Advertisement
Ranee Mehra, MD is the Director of Head and Neck Medical Oncology and Professor of Medicine at the Marlene and Stewart Greenebaum Comprehensive Cancer Center.
Articles by Ranee Mehra, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Allogeneic CD70 CAR T-Cell Therapy Shows Activity in Refractory Kidney Cancer
2
Indefinite Myeloma Maintenance Shows No OS Benefit vs 2-Year Duration
3
Pembrolizumab Plus Denosumab Shows Activity in Pretreated Kidney Cancer
4
Final RELEVANCE Data Affirm R2 as Chemo-Free Alternative in Untreated FL
5